Targeting TCA cycle through Cuproptosis confers Synthetic Lethality to ARID1A Deficiency Hepatocellular Carcinoma [Cut&Run]
To further explore the mechanisms of  glucose metabolic reprogramming in ARID1A deficiency HCC, we conducted multi-omics profilings in ARID1A deficient and wild type Hep3B cells. Overall design: Cleavage under targets and Release using nuclease (Cut-and-Run) for ARID1A or HIF-1a cells in Hep3B cells